首页> 外文期刊>Journal of interventional cardiology >Contrast-induced nephropathy in patients undergoing elective and urgent procedures
【24h】

Contrast-induced nephropathy in patients undergoing elective and urgent procedures

机译:接受选择性和紧急手术的患者的造影剂肾病

获取原文
获取原文并翻译 | 示例
       

摘要

Contrast-induced nephropathy (CIN) is an acute and severe complication after contrast media administration. The most important step in preventing CIN is identifying high-risk patients. In this review, we evaluate and summarize the evidence regarding the CIN prophylaxis, including the withdrawal of the potentially nephrotoxic drugs, hydration by isotonic solution or NaHCO 3, pharmaceutical treatment with N-acetylcysteine (N-AC), adenosine antagonists, ascorbic acid, renal procedures including hemofiltration or dialysis, and to the optimal use of the contrast. We suggest it is possible to reduce the burden of CIN by carefully incorporating these recommendations. After review of published literature in this field, we conclude that the cornerstone of the CIN prevention should be combination of hydration (normal saline or NaHCO 3) and the use of N-AC.
机译:造影剂注射后,造影剂诱发的肾病(CIN)是一种急性和严重的并发症。预防CIN的最重要步骤是识别高危患者。在这篇综述中,我们评估和总结了有关CIN预防的证据,包括戒断潜在的肾毒性药物,等渗溶液或NaHCO 3的水合作用,N-乙酰半胱氨酸(N-AC),腺苷拮抗剂,抗坏血酸,肾脏手术包括血液滤过或透析,并以最佳的对比使用。我们建议,通过仔细考虑这些建议,可以减轻CIN的负担。在回顾了该领域的公开文献之后,我们得出结论,预防CIN的基础应该是水合(生理盐水或NaHCO 3)和使用N-AC的结合。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号